RARRES2 and rheumatoid arthritis: In particular, ERA patients with Chemerin plasma values ≥ 95.7 ng/ml had more likely a moderate-high disease activity (46.6%) compared to RA patients with Chemerin plasma values < 95.7 ng/ml (27.6%; p = 0.01).